Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Soligenix Inc (NQ: SNGX )

1.632 USD +0.022 (+1.36%)
Streaming Delayed Price Updated: 2:50 PM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 22,132,060
Open 1.830
Bid (Size) 1.630 (14)
Ask (Size) 1.640 (55)
Prev. Close 1.610
Today's Range 1.539 - 1.890
52wk Range 1.210 - 3.200
Shares Outstanding 16,517,791
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Soligenix Announces Positive Progress in the Pre-clinical Development of its COVID-19 Vaccine
- Broad and potent immune responses demonstrated with full length Spike protein antigen 
From PR Newswire
Soligenix Provides Important Highlights and Upcoming Catalysts in Corporate Update Letter
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet... 
From PR Newswire

Performance

YTD
+20.88%
+20.88%
1 Month
+3.28%
+3.28%
3 Month
-29.35%
-29.35%
6 Month
-12.97%
-12.97%
1 Year
-45.05%
-45.05%

More News

Read More
Soligenix is Ready for Commercialization of SGX301 (HyBryte(TM)); FDA Has Approval Process on Fast Track
From NewMediaWire
Soligenix is Ready for Commercialization of SGX301 (HyBryte(TM)); FDA Has Approval Process on Fast Track
From Newsfile Corp News Releases
Soligenix to Present at the 2021 BIO CEO & Investor Digital Conference
From PR Newswire
Best Penny Stocks To Buy On Robinhood This Week? 5 To Watch Now
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Soligenix's Upcoming Catalysts Highlight Growth Potential as it Sheds Light on its Commercialization of SGX301
From NewMediaWire
Soligenix's Upcoming Catalysts Highlight Growth Potential as it Sheds Light on its Commercialization of SGX301
From Newsfile Corp News Releases
Soligenix Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell Lymphoma
From PR Newswire
5 Cheap Penny Stocks To Buy Under $5, Are They Worth The Risk?
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Soligenix Poised to Announce US Commercialization Plans of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma
From Newsfile Corp News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]